Heart Failure and Cardiomyopathies
The Heart Failure and Cardiomyopathies Learning Pathway includes many new and hot topics as well as debates and panel discussions related to the broad array of complexities and comorbidities that cardiovascular professionals face in patient care every day. Other sessions focus on the topic of treating patients with heart failure in a time of transition in the business aspects of medicine.
The hot topics begin with session #611, Seminal Talks in Heart Failure: I Wanna New Drug; and the Updated Heart Failure Guidelines, which includes the Kanu and Docey Chatterjee Lecture presented by Mariell Jessup. Following the lecture, presenters turn toward the hot topic of the updated Heart Failure Guidelines, which include the addition of new therapeutics sacubitril/valsartan and ivabradine. For other high interest topics and important updates, don’t miss these sessions:
- Surgical Therapies for Heart Failure Patients: Stage A-C (session #612)
- Can You See Me Now? Sensors for Monitoring Heart (session #628)
- Genetic Testing for Cardiomyopathies (session #641)
- Meeting of the Minds: HF and EP Decision Making for Complex Patients (session #687)
Some sessions deal with the challenges of treating patients who combine heart failure with other comorbidities or who have other conditions that make their treatment more complex. These informative sessions make use of case presentations, debates, panel discussions and question and answer periods to provide attendees with a thorough look at these important topics:
- Special Hearts: The Challenge of Heart Failure in Congenital Heart Disease (session #642)
- The Heavy Heart: Practicing Heart Failure Cardiology in an Obesity Epidemic (session #686)
- Pregnancy and Heart Disease (session #716)
- Heart Failure and Cancer Care (session #744)
Both medical care delivery and fee reimbursement systems in the U.S. are in the middle of major shifts in how they are handled. The transitions have created special challenges for many cardiovascular care teams. Two sessions in particular take up some of the questions and challenges raised by these transitions:
- Heart Failure Society of America and ACC Joint Symposium: Heart Failure Patient Care: Transitioning the Cost, Care and Context divides into three breakouts: Evolving Cost Models of Care—Who Pays and for What; The Heart Failure Clinic Revisited; Team Management: Practicalities and Pitfalls (session #670)
- Readmission in Heart Failure: Questions Unanswered (session #730) speaks to the challenges faced by the entire cardiovascular care team, particularly administrators, in dealing with hospital readmissions
The HF and Cardiomyopathies Pathway reviews such a broad array of complex issues many cardiovascular teams face in treating patients with heart failure, and the sessions provide ideas that will enable the teams to enhance care for their patients. For that reason, all members of the HF team need to attend these sessions. After attending ACC.17, you and your team will feel and be more fully prepared to meet the many new and existing challenges of treating patients with heart failure and cardiomyopathies and elevating patient care in this time of change and discovery.